Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
UMC Utrecht
ViroMissile, Inc.
AstraZeneca
Duke University
Washington University School of Medicine
Tizona Therapeutics, Inc
University of Arizona
IDEAYA Biosciences
University of Colorado, Denver
Adaptimmune
xCures
Daiichi Sankyo
Oscotec Inc.
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
National Institutes of Health Clinical Center (CC)
Elephas
Pfizer
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
BicycleTx Limited
University of Colorado, Denver
Bolt Biotherapeutics, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center
ITM Oncologics GmbH
Actym Therapeutics, Inc.
Maastricht University Medical Center
Maastricht Radiation Oncology
Washington University School of Medicine
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Exelixis
MacroGenics
Incyte Corporation
The Netherlands Cancer Institute
Brigham and Women's Hospital
A2 Biotherapeutics Inc.
Marengo Therapeutics, Inc.
Genentech, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
UNICANCER
DEKA Biosciences